🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Skincare brand Be Clinical raises seed round led by V3 Ventures

EntrackrEntrackr · 22d ago
Skincare brand Be Clinical raises seed round led by V3 Ventures
Medial

Skincare brand Be Clinical raises seed round led by V3 Ventures Skincare brand Be Clinical has raised Rs 6 crore in a seed funding round led by V3 Ventures, with participation from Titan Capital, founded by Kunal Bahl and Rohit Bansal, who have doubled down on their commitment to the brand. The Mumbai-based brand had previously mopped up Rs 2 crore in the same funding round led by Titan Capital, along with participation from P-TAL founder Aditya Agarwal. The proceeds will be used for research and development to strengthen in-house formulation capabilities, conduct clinical testing, and develop targeted solutions for ageing concerns across the face, body, and scalp, Be Clinical said in a press release. Launched in May last year by Hemangi Dhir, Be Clinical is an evidence-led skincare brand offering clinically tried solutions for ageing skin, developed specifically for Indian skin and conditions. Backed by in-house research and dermatologically active ingredients, the brand addresses ageing concerns with a strong focus on transparency, education, and measurable results. Be Clinical aims to address a gap in the Indian skincare market such as the lack of science-led, transparent, and clinically validated solutions designed specifically for Indian skin and environmental conditions. The brand says that it differentiates itself through in-vivo tested, clinically validated formulations, supported by end-to-end in-house research and manufacturing and responsible formulation. Since its inception, Be Clinical claims that it has demonstrated strong early traction in a short period and served over 25,000 customers, reflecting rapid adoption and growing consumer trust in its clinically driven, India-specific skincare solutions. The company plans to expand its manufacturing facility by adding advanced machinery to improve production capacity, consistency, and quality control. The brand aspires to upgrade packaging with functional, protective, and premium formats that preserve ingredient efficacy while reinforcing the brand’s clinical-grade positioning. It competes with other notable players such as Olay, Neutrogena, Clinique, and Dr. Sheth in the anti-ageing category.

Titan Capital leads seed round in skincare brand Be Clinical

EntrackrEntrackr · 8m ago
Titan Capital leads seed round in skincare brand Be Clinical
Medial

Titan Capital leads seed round in skincare brand Be Clinical Skincare brand Be Clinical has secured Rs 2 crore in a seed funding round led by Titan Capital, along with participation from P-TAL founder Aditya Agarwal. The proceeds will be utilized to internalize its manufacturing operations, ensuring enhanced oversight of inventory, increased operational efficiency, and protection of proprietary formulations, Be Clinical said in a press release. Launched by Himangi Dhir, Be Clinical is a science-led skincare brand that focuses on advanced anti-ageing solutions. The brand leverages medical-grade formulations and clinical expertise to offer targeted, results-driven products that support skin longevity at every stage of life. The startup is committed to transparency, efficacy, and innovation. The Mumbai-based company aims to accelerate its mission of providing advanced, targeted anti-ageing solutions and to set new benchmarks for quality and transparency in skincare. The brand plans to enter additional anti-ageing segments, expanding its portfolio of clinically validated solutions focused on skin longevity. The brand addresses a real and growing need—especially among Indian Gen Z and Millennial consumers, who are now seeking targeted, effective solutions earlier in their skincare journey.

Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi

EntrackrEntrackr · 2d ago
Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi
Medial

Precision oncology startup 4baseCare has raised Rs 90 crore ($9.8 million) in the first close of its Series B round co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital. The new round comes after a gap of two years. In 2024, the company had raised $6 million in Series A funding, led by Yali Capital, with participation from Infosys. The fresh capital will be used to expand 4baseCare’s hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. It will also scale its AI-powered precision oncology platform, OncoTwin, which supports clinical decision-making for cancer treatment. Founded by Hitesh Goswami, 4baseCare focuses on building population-relevant clinico-genomic datasets to improve cancer diagnosis and treatment outcomes in underrepresented populations. Its platform integrates genomic testing with real-world clinical and outcomes data to generate actionable insights for oncologists. The OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center, New York. The company works closely with hospitals to offer genomics-led cancer diagnostics within clinical settings and is positioning itself to scale across emerging markets. Investor interest in cancer-focused startups has picked up in recent years. Last year, Everhope Oncology raised $10 million in seed funding, and MOC Cancer Care & Research Centre secured $18 million led by Elevation Capital. ErlySign, OnCare, and OneCell Diagnostics are also among the funded startups.

Download the medial app to read full posts, comements and news.